Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Androgenetic alopecia treatments focus on reducing hair loss by targeting hormones, with new therapies showing promise but needing more research.

High levels of 3 alpha-diol glucuronide in the blood are a marker of increased androgen action in women with excessive hair growth of unknown cause.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

Older men with low levels of a testosterone byproduct had a higher chance of developing an irregular heartbeat.

Lower testosterone levels may increase heart failure risk in older men.

Acanthus ebracteatus Vahl. extract and verbascoside may help prevent hair loss and promote hair growth due to their anti-inflammatory properties and ability to protect against cell death.

Colostrum-derived exosomes can promote hair growth and may be a promising treatment for hair loss.

Dihydrotestosterone treatment on 2D and 3D-cultured skin cells slows down hair growth by affecting certain genes and could be a potential target for hair loss treatment.

Nutritional supplements can help manage hair loss and promote hair growth by strengthening hair roots and countering harmful effects of pollution, smoking, and deficiencies in vitamins and minerals.

A condition with certain scalp changes may come before acne keloidalis nuchae and other similar hair loss disorders.

The microneedle patch with quercetin, zinc, and copper effectively promotes hair regrowth for androgenic alopecia.

Targeting the p300/AR axis may help treat polycystic ovary syndrome.

Fibroblasts play a key role in hair loss by affecting hair growth and causing inflammation.

New treatments for alopecia show promise in restoring hair growth by targeting immune and hormonal factors.

Broccoli sprout extract may help regrow hair by improving hormone metabolism.

Stem cell-derived exosomes could be a promising new treatment for hair regrowth.

Blocking CXCL12 can reverse hair loss and fibrosis in androgenetic alopecia.

Targeting EMT and fibrotic remodeling may help treat androgenetic alopecia.

Targeting multiple pathways may improve treatments for androgenetic alopecia.

Androgenic alopecia is mainly caused by DHT, and new treatments focus on hair regeneration and aging factors.

Bovine milk-derived exosomes may improve skin, hair, gut, brain, and bone health.

MitoQ may help treat hair loss by boosting hair growth pathways.

Lack of sleep in mice leads to prostatitis by reducing certain hormones and activating an inflammatory pathway, which can be temporarily fixed with normal sleep.

Ginsenoside Rg3 combined with minoxidil was more effective in treating hair loss in mice.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

miRNA-based therapies show promise for treating skin diseases, including hair loss, in animals.

Substances from fat-derived stem cells can promote hair growth and counteract hormone-related hair loss by activating a key hair growth pathway.

Topical finasteride might be a good alternative for hair loss treatment with fewer side effects, but more research is needed.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.